This article points out that patients with pulmonary arterial hypertension (PAH) have elevated levels of endothelial progenitor cells (EPCs), illustrating an increase in bone marrow-derived cells that may be caused by elevated pulmonary pressure mobilizing these cells from the bone marrow.